Mild Traumatic Brain Injury Treatment Market, By Device Type (Imaging Devices (Computed Tomography Devices, Magnetic Resonance Imaging, X-Ray, and Others), Clinical Examination Devices, and Monitoring Devices (Invasive Monitoring Devices and Non-Invasive Monitoring Devices)), By Technique (Intracranial Pressure Monitoring (ICP) and Partial Pressure of Oxygen in Brain Tissue (pBrO2)), By End-Users (Hospitals, Diagnostic Imaging Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Report Code: PMI265619 | Publish Date: January 2024 | No. of Pages: 186

Global Mild Traumatic Brain Injury Overview

Mild Traumatic Brain Injury also called as concussion where an injury to the brain caused from externally inflicted trauma which causes damage to the blood vessels and brain cells. The symptoms includes, any loss of memory for events before or after an accident, loos of consciousness, and others.

Global Mild Traumatic Brain Injury Dynamics

Drivers

Restrains

Rising number of road accidents across globe

High costs

Growing geriatric population

 

Increased number of clinical trials worldwide in order to develop effective therapies for TBI

 

New launched product and increased product approval

 
Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Mild Traumatic Brain Injury Segmentation

The target market is segmented based on Device Type, Technique, End-Users, and Region.

Device Type Insight

On the basis of Device Type, the target market is segmented into Imaging Devices (Computed Tomography Devices, Magnetic Resonance Imaging, X-Ray, and Others), Clinical Examination Devices, and Monitoring Devices (Invasive Monitoring Devices and Non-Invasive Monitoring Devices.

Technique Insight

On the basis of Technique, the target market is segmented into Intracranial Pressure Monitoring (ICP) and Partial Pressure of Oxygen in Brain Tissue (pBrO2).

End-Users Insight

On the basis of End-Users, the target market is segmented into Hospitals, Diagnostic Imaging Centers, and Others.

Regional Insights:

On region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period.     

  • Rising prevalence of traumatic brain injury diseases.
  • Continuous technological development.
  • Presence of major players.
  • Increased number of product approvals.
  • Well-developed healthcare infrastructure.

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period.      

  • Rising awareness among patients regarding mild traumatic brain injury treatment.
  • Improved healthcare infrastructure.
  • Growing number of players operating in medical industry to develop lower costs and improve mild traumatic brain injury treatment reliability in expanding markets such as India and China.
Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Recent Development:

             The New Launched Product News,

  • In March 2023, Abbott received U.S. FDA (Food and Drug Administration) clearance for its first commercially available lab-based blood test to detect concussion also called as mild traumatic brain injury (TBI). The test “i-STAT TBI” which runs on Abbott’s Alinity i laboratory instrument provides clinicians to quickly access individuals with mild TBIs. The test is widely available in hospitals at United States.

 

Report Scope:

Attribute

Details

Base year for estimation

2022

Forecast period

2022 – 2032

Market representation

Revenue in USD Billion & CAGR from 2022 to 2032

Market Segmentation

By Device Type - Imaging Devices (Computed Tomography Devices, Magnetic Resonance Imaging, X-Ray, and Others), Clinical Examination Devices, and Monitoring Devices (Invasive Monitoring Devices and Non-Invasive Monitoring Devices

By Technique - Intracranial Pressure Monitoring (ICP) and Partial Pressure of Oxygen in Brain Tissue (pBrO2).

By End-Users - Hospitals, Diagnostic Imaging Centers, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032.

Few Other Promising Reports:

Global Mild Traumatic Brain Injury Key Players

The key players operating the target market includes, TEVA Pharmaceutical Industries Ltd., Neuren Pharmaceuticals Ltd., Medtronic plc., NeuroScience Pharmaceuticals, Tenax Therapeutics, Inc., Vasopharm GmbH, Amarantus Bio Science Holdings Inc., Silver Creek Pharmaceuticals, Inc., Stemedica Cell Technologies, Inc., Banayan Biomarkers, Inc.

Global Mild Traumatic Brain Injury Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Device Type
      • Market Snippet, By Technique
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  4. Global Mild Traumatic Brain Injury Treatment Market, By Device Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Imaging Devices
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Computed Tomography Devices
        • Magnetic Resonance Imaging
        • X-Ray
        • Others
    • Clinical Examination Devices
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Monitoring Devices
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Invasive Monitoring Devices
        • Non-Invasive Monitoring Devices
  5. Global Mild Traumatic Brain Injury Treatment Market, By Technique, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Intracranial Pressure Monitoring (ICP)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Partial Pressure of Oxygen in Brain Tissue (pBrO2)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Mild Traumatic Brain Injury Treatment Market, By End-User, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diagnostic Imaging Centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Mild Traumatic Brain Injury Treatment Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Device Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technique, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Device Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technique, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Device Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technique, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Device Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technique, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Device Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technique, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
      • TEVA Pharmaceutical Industries, Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Neuren Pharmaceuticals, Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Tenax Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • IschemixInc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Grace Laboratories LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Silver Creek Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Stemedica Cell Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • NeuroScience Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Vasopharm GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • AmarantusBioScience Holdings
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Banayan Biomarkers, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  10. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The growing adoption of innovative technology and new areas of research will potentially change the TBI management that includes, treatment techniques, biomarkers and medications which in turn, is expected to fruitful the demand for target market growth.

By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the target market includes, TEVA Pharmaceutical Industries Ltd., Neuren Pharmaceuticals Ltd., Medtronic plc., NeuroScience Pharmaceuticals, Tenax Therapeutics, Inc., Vasopharm GmbH, Amarantus Bio Science Holdings Inc., Silver Creek Pharmaceuticals, Inc., Stemedica Cell Technologies, Inc., Banayan Biomarkers, Inc.